Xenetic Biosciences, Inc.
USD2.99
+0.14 (+4.91%)
CEO
James F. Parslow
IPO Date
2016-06-30
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$2.96
Prev. Close
$2.85
Day Low
$2.74
Day High
$3.05
52W Low
$1.90
52W High
$13.93
Market Cap
$0.01B
Volume
0.05M
| -1.6 |
| 31 Dec 2023 | FY | 100.0% | -162.8% | -42.2% | -39.0% | 0.00 | 11.84 | -1.3 |
| 31 Dec 2022 | FY | 100.0% | -383.9% | -48.0% | -44.5% | 0.00 | 12.72 | -0.6 |
| 31 Dec 2021 | FY | 100.0% | -486.4% | -30.7% | -28.5% | 0.00 | 13.18 | -2.3 |
| 31 Dec 2020 | FY | 100.0% | -2493.1% | -89.2% | -82.7% | 0.01 | 13.20 | -1.2 |
| 31 Dec 2019 | FY | 100.0% | -74856.6% | -74.2% | -59.3% | 0.00 | 7.84 | -0.3 |
| 31 Dec 2018 | FY | 0.0% | 0.0% | -73.6% | -50.6% | 0.00 | 0.75 | -2.0 |
| 31 Dec 2017 | FY | 97.9% | -47.4% | -25.1% | -18.8% | 0.00 | 3.03 | -4.6 |
| 31 Dec 2016 | FY | 98.8% | -1806.9% | -335.2% | -258.4% | 0.00 | 4.47 | -0.6 |
| -2.1 |
| 30 Sept 2025 | Q3 | 100.0% | -49.7% | -12.9% | -10.1% | 0.00 | 4.56 | -2.4 |
| 30 Jun 2025 | Q2 | 100.0% | -116.7% | -15.5% | -12.9% | 0.00 | 5.93 | -2.2 |
| 31 Mar 2025 | Q1 | 100.0% | -152.2% | -17.6% | -15.6% | 0.00 | 8.20 | -1.1 |
| 31 Dec 2024 | Q4 | 100.0% | -162.5% | -17.6% | -15.3% | 0.00 | 7.37 | -1.5 |
| 30 Sept 2024 | Q3 | 100.0% | -71.1% | -6.2% | -5.4% | 0.00 | 6.96 | -3.8 |
| 30 Jun 2024 | Q2 | 100.0% | -175.4% | -17.1% | -14.1% | 0.00 | 5.05 | -1.3 |
| 31 Mar 2024 | Q1 | 100.0% | -234.0% | -13.8% | -12.7% | 0.00 | 11.69 | -1.4 |
| 31 Dec 2023 | Q4 | 100.0% | -174.3% | -12.0% | -11.0% | 0.00 | 11.84 | -1.1 |